BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8103064)

  • 1. CD30 is a signal-transducing molecule that defines a subset of human activated CD45RO+ T cells.
    Ellis TM; Simms PE; Slivnick DJ; Jäck HM; Fisher RI
    J Immunol; 1993 Sep; 151(5):2380-9. PubMed ID: 8103064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-12 activates IFN-gamma production through the preferential activation of CD30+ T cells.
    Alzona M; Jäck HM; Fisher RI; Ellis TM
    J Immunol; 1995 Jan; 154(1):9-16. PubMed ID: 7995963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD30 defines a subset of activated human T cells that produce IFN-gamma and IL-5 and exhibit enhanced B cell helper activity.
    Alzona M; Jäck HM; Fisher RI; Ellis TM
    J Immunol; 1994 Oct; 153(7):2861-7. PubMed ID: 8089475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the costimulatory receptor CD30 is regulated by both CD28 and cytokines.
    Gilfillan MC; Noel PJ; Podack ER; Reiner SL; Thompson CB
    J Immunol; 1998 Mar; 160(5):2180-7. PubMed ID: 9498756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of CD27 expression on subsets of mature T-lymphocytes.
    Hintzen RQ; de Jong R; Lens SM; Brouwer M; Baars P; van Lier RA
    J Immunol; 1993 Sep; 151(5):2426-35. PubMed ID: 7689607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
    Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
    Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD30-regulated apoptosis in murine CD8 T cells after cessation of TCR signals.
    Telford WG; Nam SY; Podack ER; Miller RA
    Cell Immunol; 1997 Dec; 182(2):125-36. PubMed ID: 9514701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential activation of p21ras in CD45RA+ and CD45RO+ human T lymphocytes.
    Patel HR; Renz H; Terada N; Gelfand EW
    J Immunol; 1994 Mar; 152(6):2830-6. PubMed ID: 8144884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of CD40 ligand on T cell subsets. Implications for different roles of CD45RA+ and CD45RO+ cells in IgE production.
    Patel HR; Oshiba A; Jeppson JD; Gelfand EW
    J Immunol; 1996 Mar; 156(5):1781-87. PubMed ID: 8596027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The kinetics and temporal expression of T-cell activation-associated antigens CD15 (LeuM1), CD30 (Ki-1), EMA, and CD11c (LeuM5) by benign activated T cells.
    Chadburn A; Inghirami G; Knowles DM
    Hematol Pathol; 1992; 6(4):193-202. PubMed ID: 1362727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD27 is a signal-transducing molecule involved in CD45RA+ naive T cell costimulation.
    Kobata T; Agematsu K; Kameoka J; Schlossman SF; Morimoto C
    J Immunol; 1994 Dec; 153(12):5422-32. PubMed ID: 7989747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential responses of invariant V alpha 24J alpha Q T cells and MHC class II-restricted CD4+ T cells to dexamethasone.
    Milner JD; Kent SC; Ashley TA; Wilson SB; Strominger JL; Hafler DA
    J Immunol; 1999 Sep; 163(5):2522-9. PubMed ID: 10452989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficient CD4+ T cell proliferation in the class 1 MHC-restricted 2C TCR-transgenic mouse.
    Chen FL; Kung JT
    J Immunol; 1996 Mar; 156(6):2036-44. PubMed ID: 8690890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of peripheral blood lymphocyte stimulation on zeta chain expression and IL-2 production in Hodgkin's disease.
    Frydecka I; Boćko D; Kosmaczewska A; Ciszak L; Morilla R
    Br J Cancer; 2001 May; 84(10):1339-43. PubMed ID: 11355944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD45RO expression on bovine T cells: relation to biological function.
    Bembridge GP; MacHugh ND; McKeever D; Awino E; Sopp P; Collins RA; Gelder KI; Howard CJ
    Immunology; 1995 Dec; 86(4):537-44. PubMed ID: 8567018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential capacities of CD4+, CD8+, and CD4-CD8- T cell subsets to express IL-18 receptor and produce IFN-gamma in response to IL-18.
    Tomura M; Maruo S; Mu J; Zhou XY; Ahn HJ; Hamaoka T; Okamura H; Nakanishi K; Clark S; Kurimoto M; Fujiwara H
    J Immunol; 1998 Apr; 160(8):3759-65. PubMed ID: 9558078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-induced CD3-CD4 coligation inhibits TCR/CD3 activation in the absence of costimulatory signals in normal mouse CD4(+) T lymphocytes.
    Portolés P; de Ojeda G; Criado G; Fernández-Centeno E; Rojo JM
    Cell Immunol; 1999 Aug; 195(2):96-109. PubMed ID: 10448009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD3 antigen-mediated calcium signals and protein kinase C activation are higher in CD45R0+ than in CD45RA+ human T lymphocyte subsets.
    Robinson AT; Miller N; Alexander DR
    Eur J Immunol; 1993 Jan; 23(1):61-8. PubMed ID: 8419189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An anti-CD30 chimeric receptor that mediates CD3-zeta-independent T-cell activation against Hodgkin's lymphoma cells in the presence of soluble CD30.
    Hombach A; Heuser C; Sircar R; Tillmann T; Diehl V; Pohl C; Abken H
    Cancer Res; 1998 Mar; 58(6):1116-9. PubMed ID: 9515791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulated expression of a receptor for hyaluronan-mediated motility on human thymocytes and T cells.
    Pilarski LM; Miszta H; Turley EA
    J Immunol; 1993 May; 150(10):4292-302. PubMed ID: 7683315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.